Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid

Introduction Basal cell carcinoma (BCC) is the most common malignant neoplasm of the eyelids and surrounding structures, usually developing in the area of the lower lid and medial canthus. Invasive forms of BCC are connected with a high risk of recurrence, often due to incomplete excision of these lesions. Aim Clinical and pathological analysis of recurrent BCCs of the eyelids and surrounding structures. Material and methods We present clinical and pathological analysis including immunohistochemical reaction to Ki-67 antigen of 19 patients (11 women, 8 men) operated for recurrent BCCs of the eyelids in 2000–2012. Results In most cases, recurrences were present on the lower lid and in the medial canthus. In 15 patients the histopathological type did not change and in 4 cases it transformed into more invasive forms. The values of Ki-67 index for primary BCCs ranged between 1% and 20%, and for relapsing lesions between 11% and 48%. Conclusions Proper clinical and pathological evaluation to determine the risk of relapse in BCCs of the eyelids and surrounding structures should include the analysis of prognostic factors, in particular location and size, histopathological type and radicalness of surgical treatment of primary BCCs. Clinical and pathological analysis of patients with recurrent BCC of the eyelids and surrounding structures should be combined with the evaluation of proliferation index Ki-67, which is essential for prognosis and choice of the appropriate therapeutic method.

[1]  P. Golusiński,et al.  Analysis of selected recurrence risk factors after treatment of head and neck basal cell carcinoma , 2014, Postepy dermatologii i alergologii.

[2]  M. Péč,et al.  Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. , 2011, Acta Dermatovenerologica Alpina Pannonica et Adriatica.

[3]  R. Vieira,et al.  Incidence and factors associated with recurrence after incomplete excision of basal cell carcinomas: a study of 90 cases , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  A. Crowson Biopsy Interpretation of the Skin , 2010 .

[5]  G. Muțiu,et al.  Eyelid tumors: histopathological and clinical study performed in County Hospital of Oradea between 2000-2007. , 2010, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[6]  P. Birembaut,et al.  Aneuploidy, but not Ki‐67 or EGFR expression, is associated with recurrences in basal cell carcinoma , 2008, Journal of cutaneous pathology.

[7]  P. Walker,et al.  Surgical treatment of basal cell carcinomas using standard postoperative histological assessment , 2006, The Australasian journal of dermatology.

[8]  P. Leboit,et al.  Pathology and genetics of skin tumours , 2006 .

[9]  C. Shields,et al.  Sebaceous carcinoma of the ocular region: a review. , 2005, Survey of ophthalmology.

[10]  G. Renard,et al.  Basal Cell Carcinomas of the Eyelids , 2005, Ophthalmologica.

[11]  A. Nasierowska-Guttmejer „Patologia znaczy słowo o chorobie" (Jerzy Stachura, Wenancjusz Domagała) , 2005 .

[12]  C. Sotozono,et al.  Ki-67 Labeling Index as a Marker of Malignancy in Ocular Surface Neoplasms , 2004, Japanese Journal of Ophthalmology.

[13]  J. Bonnetblanc,et al.  Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions , 2004, The British journal of dermatology.

[14]  M. Sułkowska,et al.  An evaluation of Ki-67 and PCNA expression in conjunctival and eyelid tumours. , 2004, Folia Morphologica.

[15]  R. Dummer,et al.  Superficial radiotherapy for patients with basal cell carcinoma , 2003, Cancer.

[16]  Harjinder S. Dhaliwal,et al.  Clinicopathologic features and behavior of cutaneous eyelid melanoma. , 2002, Ophthalmology.

[17]  M. Maloney,et al.  The significance of tumor persistence after incomplete excision of basal cell carcinoma. , 2002, Journal of the American Academy of Dermatology.

[18]  G. Bartley,et al.  Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. , 2001, Ophthalmology.

[19]  K. Nouri,et al.  Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication? , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[20]  A. Kopf,et al.  Recurrence rates of treated basal cell carcinomas. , 1993, The Journal of dermatologic surgery and oncology.

[21]  C. Grin,et al.  Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. , 1991, The Journal of dermatologic surgery and oncology.

[22]  D. Jones,et al.  Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. , 1990, Journal of the American Academy of Dermatology.

[23]  W. Green,et al.  Squamous cell carcinoma of the eyelids. , 1987, Ophthalmology.